logo
  • About
    • Initiative Overview
    • Steering Committee
    • Content Development Committee
  • Provider Corner
    • Call For Cases for MSGERC Town Hall
    • Call For Cases
    • Care Step Pathways on COVID-19-Associated IFIs
    • OFID Publication
    • CCN Publication
    • Continuing Education
    • Dermatophyte Infographic
    • Mucormycosis Infographic
  • News and Events
    • Interim Guidance Matamoros FM Outbreak 5_20_23
    • Emerging Treatment Failures in Dermatophyte Infections Survey
    • MSGERC Grand Rounds Webinar Series
      • Cutaneous Manifestations of Fungal Infections
      • Candida auris FAQs
      • The WHO Fungal Priority List
      • Invasive Candidiasis
      • Cryptococcosis
      • Invasive Mold Infections
      • Community-acquired Pneumonia
    • Open Myc Series
      • Open Myc – Fungal Threats
      • Open Myc for Emerging COVID-19-Associated Fungal Infections
      • Open Myc for Fungal Disease Awareness Week
      • Open Myc on Covid-19 and Mucormycosis
    • COVID-19 and Fungus MSGERC Virtual Collaborative
    • Latin American Forum on Invasive Fungal Infections
    • Mucor Podcast with the IDSA
    • Newsfeed
  • Resources
    • CA-IFI Color Code
    • Presentations
    • Healthcare Disparities and COVID-19-Associated IFIs
    • CDC Fungal Resources
    • Dr. Fungus
    • MSGERC
  • Patient and Caregiver Corner
    • Open Myc – Fungal Threats
    • CA-IFI Admission Handout
    • CDC Patient Materials
    • Patient Videos
    • Superficial Fungal Infections Infographic
    • Mucormycosis Infographic
  • Contact
  • About
    • Initiative Overview
    • Steering Committee
    • Content Development Committee
  • Provider Corner
    • Call For Cases for MSGERC Town Hall
    • Call For Cases
    • Care Step Pathways on COVID-19-Associated IFIs
    • OFID Publication
    • CCN Publication
    • Continuing Education
    • Dermatophyte Infographic
    • Mucormycosis Infographic
  • News and Events
    • Interim Guidance Matamoros FM Outbreak 5_20_23
    • Emerging Treatment Failures in Dermatophyte Infections Survey
    • MSGERC Grand Rounds Webinar Series
      • Cutaneous Manifestations of Fungal Infections
      • Candida auris FAQs
      • The WHO Fungal Priority List
      • Invasive Candidiasis
      • Cryptococcosis
      • Invasive Mold Infections
      • Community-acquired Pneumonia
    • Open Myc Series
      • Open Myc – Fungal Threats
      • Open Myc for Emerging COVID-19-Associated Fungal Infections
      • Open Myc for Fungal Disease Awareness Week
      • Open Myc on Covid-19 and Mucormycosis
    • COVID-19 and Fungus MSGERC Virtual Collaborative
    • Latin American Forum on Invasive Fungal Infections
    • Mucor Podcast with the IDSA
    • Newsfeed
  • Resources
    • CA-IFI Color Code
    • Presentations
    • Healthcare Disparities and COVID-19-Associated IFIs
    • CDC Fungal Resources
    • Dr. Fungus
    • MSGERC
  • Patient and Caregiver Corner
    • Open Myc – Fungal Threats
    • CA-IFI Admission Handout
    • CDC Patient Materials
    • Patient Videos
    • Superficial Fungal Infections Infographic
    • Mucormycosis Infographic
  • Contact
Avatar photo
  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

Viewing 6 topics - 1 through 6 (of 6 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • hepatotoxicity

      Started by: yael silman in: Side-effect management

    • 5
    • 6
    • February 23, 2018 at 5:48 pm

      Mollie Reed

    • Adjuvant pembrolizumab

      Started by: LisaTushla in: Expectations for therapy

    • 4
    • 4
    • February 19, 2018 at 10:50 pm

      Suzanne McGettigan

    • Infusion times

      Started by: Avatar photoLisa Kottschade in: Dosing and administration

    • 8
    • 11
    • February 15, 2018 at 3:41 pm

      Lisa Kottschade

    • How would you manage?

      Started by: Avatar photoKrista Rubin in: Side-effect management

    • 4
    • 4
    • January 23, 2018 at 8:51 pm

      Brianna Hoffner

    • Dose reductions with BRAF/MEK inhibitors

      Started by: LisaTushla in: Dosing and administration

    • 3
    • 3
    • January 22, 2018 at 11:28 pm

      Suzanne McGettigan

    • High copays

      Started by: LisaTushla in: Reimbursement

    • 2
    • 2
    • January 22, 2018 at 11:21 pm

      Suzanne McGettigan

  •  

Viewing 6 topics - 1 through 6 (of 6 total)

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2023 MSGERC and Terranova Medica LLC. All rights reserved.
  • Terms
  • Privacy